(NOTE: This item originally appeared in today’s daily briefing. It’s been expanded and rewritten here.)
DNA-based diagnostics face a fundamental, though hardly insuperable, obstacle: When you’re looking for a rare mutation or other identifying sequence of DNA “letters” (technically known as bases or nucleotides), there are rarely enough matching DNA molecules in your average blood or [...]
Posts by David P. Hamilton
TODAY’S HEADLINES:
Adnavance pulls in C$3.7M for molecular diagnostics, names new CEO (release)
“Personalized medicine” co. Proprius sells to Cypress Bio for up to $75M (release)
Vaccinex raises $25M in wake of GSK deal for antibody drugs (VentureWire)
Cianna Medical receives $9M for breast-cancer radiation treatment (release)
Electron-microscope image provider NanoImaging takes in $1.5M (release)
[...]
TODAY’S HEADLINES:
Microsoft launches $3M fund to support online health-improvement tools (release)
Clarus Ventures raises $660M life-sciences fund (release)
Iverson Genetics raises $1.1M for blood-clotting tests, seeks $9.3M more (VentureWire)
Upstart Ventures aims for $30M fund to seed Utah life-science ventures (release)
CalHealth takes in $750K for blood-pressure monitoring (VW)
Regenerative medicine co. Organogenesis acquires [...]
23andMe — the Google-backed startup that scans your genome for disease-risk factors and other information, now lets anyone see how the service works without first charging $999 for the privilege. My first impression: It packs a tremendous amount of information into clean, uncluttered pages that are still relatively easy to understand even for newcomers to [...]
(UPDATED: See below.)
As I discussed a few weeks ago with respect to deCODEme — a “personal genomics” service hurriedly launched last November by Iceland’s deCODE Genetics in an apparent attempt to beat 23andMe to market (it succeeded by a day or so) — these sorts of services can awfully dense and difficult to navigate. [...]
HemCon Medical Technologies, a Portland, Ore., startup that makes and sells high-tech bandages, said it will acquire Alltracel Pharmaceuticals, a publicly traded but barely profitable Irish healthcare conglomerate that also has a wound-care focus. The release is here.
HemCon was only founded in 2001, but hit it big almost immediately with a new type of bandage, [...]
TODAY’S HEADLINES:
HemCon Medical acquires Alltracel Pharma (release)
Transoma Medical, implantable wireless device maker, withdraws its IPO (Edgar)
Oracle Healthcare cuts Precision Thera acquisition price by roughly 15 percent (release)
MedBillManager adopts change:healthcare name, aims for March 3 relaunch release
Another slow news day, as yesterday we covered most of the fundings other sites are writing [...]
The impending — or so it’s seemed — launch of Google Health has spurred any number of comparisons, invidious and otherwise, to Microsoft’s flashier but ultimately disappointing launch of HealthVault last October.
Now that Google has finally announced its first big health project with the Cleveland Clinic, though, it’s far from clear exactly how its platform [...]
So Google Health has finally made its first formal announcement — not a splashy rollout along the lines of Microsoft’s HealthVault (see our coverage), but a limited — and closed to the public — testbed launched in partnership with the Cleveland Clinic.
Here’s what we know about the project: The Cleveland Clinic, which already has a [...]
Now that the Bioheart IPO has doubly surprised everyone — first by happening at all, and second by coming out on such dreadful terms for the company — perhaps it’s time to take a closer look at exactly where the 2008 offering market for life-science companies stands. In fact, I’ll aim to make this a [...]
TODAY’S HEADLINES:
Compact ultrasound maker Zonare Medical raises $30M (VentureWire)
TherOx raises $30M for hypersaturated-oxygen devices (peHUB)
Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release)
Population Genetics takes in £3.8M for massively parallel genome studies (GenomeWeb)
“Brain fitness” trainer Dakim raises $11M (release)
BioIQ, home-diagnostics maker, takes in $2.5M (release)
Hospital med-tracker Sabal Medical raises funds [...]
(UPDATED: See below.)
Getting stuff for free is always an attractive proposition from the consumer’s point of view, if not necessarily the greatest business model for the company doing the giving (go ahead and recall your favorite dot-com example here). Now TrialPay, a self-described arranger of “alternative payments” that just raised another $13 million, thinks it’s [...]
TODAY’S HEADLINES:
San Diego’s Ocera raises $36M for gastrointestinal treatments (release)
Antibody-drug maker Affimed pulls in €20M (release)
GraftCath, venous catheter developer, gets $12M (VentureWire)
Ranier Tech takes in £8M for spinal-disc replacements (release)
NeuWave Medical pulls in $4.5M for microwave cancer treatment (Milwaukee J-S)
Avalon Ventures closes $150M fund for biotech, wireless and Web [...]
The embattled cell-therapy startup Bioheart finally limped across the IPO goal line yesterday, but it was a Pyhrric victory. The startup, which once sought $70 million, ended up netting as little as $1.5 million. And almost half of that amount came directly from Bioheart founder Henry Leonhardt instead of outside investors.
Bioheart, of course, has had [...]
Top Stories
- CES: MySpace wants to friend your television, ...
- CES: Sony shoots for in-home, out-of-home electronics
- Panasonic swallows the 3-D hook
- Report: Facebook growing, rivals shrinking in U.S.
- Intel writes off $950M on Clearwire investment
Recent Guest Columnists
Job Board
- Web developer for online gaming service provider
at Betzya (London, but remote working possible) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2009(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress